Katalog der Deutschen Nationalbibliothek

Neuigkeiten Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
 
Neuigkeiten Dienstag 9. Dezember 2025: Die Lesesäle der Deutschen Nationalbibliothek in Leipzig öffnen wegen einer Personalversammlung erst ab 13 Uhr. // Tuesday 9 December 2025: The reading rooms of the German National Library in Leipzig will open at 13:00 due to a staff assembly.
 
 
 


Ergebnis der Suche nach: di and pietrantonio
im Bestand: Gesamter Bestand

1 - 10 von 24
<< < > >>


Artikel 1 Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer
Enthalten in Cellular oncology 8.2.2023: 1-16 		Online Ressource
Artikel 2 3D CT-Inclusive Deep-Learning Model to Predict Mortality, ICU Admittance, and Intubation in COVID-19 Patients
Enthalten in Journal of digital imaging 30.11.2022: 1-14 		Online Ressource
Artikel 3 DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients
Enthalten in The pharmacogenomics journal 6.2.2019: 1-8 		Online Ressource
Artikel 4 Rezension Donatella Di Pietrantonio, LʼArminuta. Torino: Einaudi, 2017 ISBN 9788806232108, pp. 176, Euro 17,50
Enthalten in Horizonte Bd. 3, 2018: 249-252 		Online Ressource
Artikel 5 A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study
Enthalten in BMC cancer Bd. 24, 8.4.2024, Nr. 1, date:12.2024: 1-10 		Online Ressource
Artikel 6 Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: the multicentre, phase II randomized TRINITY trial
Enthalten in BMC cancer Bd. 25, 8.4.2025, Nr. 1, date:12.2025: 1-11 		Online Ressource
Artikel 7 Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial
Enthalten in BMC cancer Bd. 19, 29.3.2019, Nr. 1, date:12.2019: 1-9 		Online Ressource
Artikel 8 AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer
Enthalten in BMC cancer Bd. 20, 22.7.2020, Nr. 1, date:12.2020: 1-9 		Online Ressource
Artikel 9 Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study
Enthalten in BMC cancer Bd. 24, 6.5.2024, Nr. 1, date:12.2024: 1-2 		Online Ressource
Artikel 10 Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study
Enthalten in World journal of surgical oncology Bd. 17, 27.3.2019, Nr. 1, date:12.2019: 1-6 		Online Ressource


1 - 10 von 24
<< < > >>




Materialarten

Alle Materialarten > Online Ressourcen (24)

Standorte

Alle Standorte > Online (frei zugänglich) (24)

Aktionen

Aktionen


E-Mail-IconAdministration